North bay, Canada Clinical Trials

A listing of North bay, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
featured
A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

atopic dermatitis
atopic dermatitis/eczema
dermatitis
NORTH BAY DERMATOLOGY CENTRE
 (0.4 away) Contact site
  • 1344 views
  • 08 Dec, 2020
  • +52 other locations
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

The purpose of the study is to evaluate the efficacy, safety, and immunogenicity of ABP 654 compared with ustekinumab in participants with moderate to severe plaque psoriasis.

North Bay Dermatology Centre Inc.
 (0.4 away) Contact site
  • 0 views
  • 26 Jun, 2021
  • +157 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Scott Shulman Medicine Professional Corporation /ID# 169113
 (0.9 away) Contact site
  • 611 views
  • 04 Aug, 2021
  • +890 other locations
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

The purpose of this study is to assess whether withdrawal of aminosalicylate (5-ASA) is non-inferior to continuation of 5-ASA therapy in Crohn's disease (CD) subjects in remission.

remission
mesalamine
aminosalicylate
Scott Shulman Medical Professional Corporation
 (0.9 away) Contact site
  • 140 views
  • 12 Apr, 2021
  • +48 other locations
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

This is a Phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy on TVB-2640 in subjects with non-alcoholic steatohepatitis (NASH). Subjects will be randomly assigned toTVB-2640 or matching placebo PO QD for 52 weeks, with the first dose administered on Day 1.

Toronto Liver Centre
 (181.1 away) Contact site
  • 0 views
  • 05 Jun, 2021
  • +65 other locations
Long-Term Study That Measures the Safety and Efficacy of BMS-986165 in Participants With Psoriasis.

The main purpose of this study is to characterize the long-term safety and efficacy of the drug BMS-986165 in patients who have been previously enrolled in an applicable Phase 3 psoriasis study.

bms-986165
North Bay Dermatology Centre
 (0.4 away) Contact site
  • 366 views
  • 26 Jan, 2021
  • +338 other locations
PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

The purpose of the study is to evaluate the safety, tolerability, and clinical efficacy of PN-943 450 mg twice daily [BID] and PN-943 150 mg BID, compared with placebo BID, in subjects with moderate to severe active Ulcerative Colitis (UC).

Protagonist Investigational Site
 (0.9 away) Contact site
  • 0 views
  • 20 Jul, 2021
  • +81 other locations
Hockey Fans in Training (Hockey FIT): Improving Men's Health Through the Power of Sport

Hockey Fans in Training (Hockey FIT) is a 12-month (3-month active phase and 9-month minimally-supported phase) weight loss and healthy lifestyle program for middle-aged, overweight/obese male hockey fans, delivered by trained coaches in collaboration with major junior or professional hockey teams and implementation partners (e.g., YMCAs, local fitness facilities, and …

YMCA of North Bay
 (0.7 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +31 other locations
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risankizumab works compared to ustekinumab. This study will assess change in Crohn's Disease Activity Index (CDAI). Risankizumab is an investigational drug being developed for the treatment of …

tumor necrosis factor
crohn's disease
tumour necrosis
abdominal pain
risankizumab
Scott Shulman Medicine Professional Corporation /ID# 223754
 (0.9 away) Contact site
  • 97 views
  • 04 Aug, 2021
  • +439 other locations
Trial of PDE4 Inhibition With Roflumilast for the Management of Seborrheic Dermatitis (STRATUM)

The study will assess the safety and efficacy of ARQ-154 foam vs vehicle applied once for 8 weeks by subjects with seborrheic dermatitis.

erythema
Arcutis Biotherapeutics Clinical Site 30
 (0.4 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +48 other locations